More than 700 hospitals and health systems are asking House and Senate leadership to protect the 340B drug discount program in light of recent regulations and legislative proposals the providers say would “undo more than two decades of bipartisan work” on the safety net. “Americans are right to be upset with the high prices being charged for new and existing …

Source: 340Binformed.org September 7, 2018—Healthcare economist Austin Frakt recently wrote in The New York Times that the 340B drug discount program includes hospitals “that don’t need the extra help” and don’t use the program to benefit low-income patients. That’s a one-sided view that ignores research showing 340B is working as Congress intended. The research Frakt overlooks includes findings that 340B hospitals care …

By Rep. Doris Matsui (D-Calif.), Opinion Contributor As a country, we are struggling to address what has become a tragic opioid epidemic gripping the nation. Our community health care providers are on the front lines of this crisis. While hospitals and clinics work tirelessly to both prevent and treat substance use disorder, they are simultaneously fending off constant threats of …

CENTENNIAL (S&P Global Ratings) May 25, 2018–S&P Global Ratings today said that it believes the impacts of the cuts to the 340B Drug Pricing Program on not-for-profit hospitals that rely on 340B drug savings will likely weaken their operating performance at a time of already tightening margins. This could lead to negative rating actions if hospital-specific funding reductions were material …

As leaders in Washington debate ways to lower prescription drug prices, it’s important to remember that many Americans are getting access to free or heavily discounted care through the crucial 340B drug pricing program. This is especially true in rural communities such as here in Boone County in central Iowa, where access to high-quality care is often threatened by economic …

By Dr. Bruce Siegel Given all the good things hospitals accomplish thanks to 340B Drug Pricing Program savings—from affordable medications to comprehensive services for the poor—it might seem odd the program has taken so much heat lately. But if you consider the larger context of the attacks—the national debate on runaway drug prices—you’ll understand why drugmakers have worked so hard …

CONSUMER GROUPS BACK 340B — More than 60 patient groups are urging congressional leaders to support the federal drug discount program that’s been the subject of intensifying congressional scrutiny ahead of another Senate HELP Committee hearing this morning. Families USA, Doctors for America, Public Citizen and others write that they “welcome vigorous oversight” but are urging lawmakers to “reject any proposals that weaken this important …

From Ryan White Clinics for 340B Access We write to respond to your February “Open Letter to Grantees” regarding your sponsorship of H.R. 4710, the 340B PAUSE Act.  We strongly agree that the 340B program is “one of Congress’ significant bipartisan achievements” and that it should be “preserved, strengthened, and protected.”  However, we are compelled to address several points made …

By John Hassell | National Director of Advocacy – AIDS Healthcare Foundation Despite the drug industry’s best efforts, at a March 15, 2018 hearing on the 340B Drug Pricing Program in the U.S. Senate’s Health, Education, Labor and Pensions (HELP) Committee, a majority of the senators who spoke made the case that the 340B program is working as intended and …

The 340B Drug Program’s intent is to help safety-net providers “stretch scarce federal resources” to provide more and better services to their clients. The 340B program is saving lives while pharma corporate interests are blaming it for high drug prices. Help save the 340B program from sneak attacks. Save the safety net. Protect and defend the 340B Drug Program. Why …